InvestorsHub Logo
Followers 234
Posts 26887
Boards Moderated 0
Alias Born 01/12/2013

Re: Biobillionair post# 217840

Saturday, 10/05/2019 7:51:16 PM

Saturday, October 05, 2019 7:51:16 PM

Post# of 425622
8-16 email chain:

Sun, Caroline
From: Park, Han <HPark@cov.com>
Sent: Friday, August 16, 2019 5:08 PM
To: Klein, Chuck; Reig, Eimeric; Fundakowski, Claire; ahodgson@winston.com;
wshaffer@laxalt-nomura.com; mrounds@bhfs.com; rcudnik@bhfs.com; Huttner,
Constance; Rodriguez, Frank; Sun, Caroline; Finkelstein, Beth; Grumka, Susan
Cc: Amarin-Vascepa; nsantoro@santoronevada.com; JSmith@santoronevada.com
Subject: Amarin Pharma Inc. et al. v. Hikma Pharmaceuticals USA Inc. et al., No. 2:16-cv-2525 -
document production
Attachments: 2019-08-16 Ltr from Amarin to defs enclosing doc prod.pdf
Counsel,
Please see the attached letter.
Regards,
Han Park
Covington & Burling LLP
One CityCenter, 850 Tenth Street, NW
Washington, DC 20001-4956
T +1 202 662 5117 | hpark@cov.com
www.cov.com
This message is from a law firm and may contain information that is confidential or legally privileged. If you are not the intended recipient, please
immediately advise the sender by reply e-mail that this message has been inadvertently transmitted to you and delete this e-mail from your system.
Thank you for your cooperation.


Via Email August 16, 2019
Claire A. Fundakowski
WINSTON & STRAWN LLP
1700 K Street N.W.
Washington, D.C. 20006
cfundakowski@winston.com
Constance S. Huttner
WINDELS MARX LANE & MITTENDORF, LLP
1 Giralda Farms, Suite 100
Madison, NJ 07940
chuttner@windelsmarx.com
Re: Amarin Pharma Inc. et al. v. Hikma Pharmaceuticals USA
Inc. et al., No. 2:16-cv-2525 (consolidated)
Dear Counsel:
Plaintiffs Amarin Pharma, Inc. and Amarin Pharmaceuticals Ireland Limited are
producing documents bearing Bates-numbers AMRN03172193–AMRN03174917. Please note
that the documents are designated “CONFIDENTIAL” and should be treated as Confidential
Material pursuant to the Discovery Confidentiality Order in the above-referenced matter. In
addition, access to the documents bearing Bates-numbers AMRN03172254–AMRN03174917
should be restricted to only Defendants’ outside counsel or in-house counsel who are not
involved with Defendants’ ANDAs for generic versions of Vascepa pursuant to the agreement
between the parties.
The documents are being produced in a password-protected zip file at a secure file
sharing site. The credentials for accessing the site will be provided in a separate email. The
password for the zip file is: @Cq3sYq3
Sincerely,
/s/ Han Park
Han Park


If you're not good at being yourself, then maybe that's being yourself!

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News